Wilms' tumor

Common Name(s)

Wilms' tumor, Wilm's Tumor

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Wilms' tumor" for support, advocacy or research.

Trisomy 18 Foundation

The Trisomy 18 Foundation (T18F) is the leading national organization devoted exclusively to improving outcomes for Trisomy 18 families in the United States. Committed to the support of medical research in finding effective treatments and preventions for Trisomy 18. The T18F also educates patient families and physicians about prevention, diagnosis and the treatment of Trisomy 18. The T18F is an active advocate for the Trisomy 18 community, helping to raise awareness of this disease and the need for treatments. The T18F's website is the premier source for educating the public about Trisomy 18 and impacted families..

Last Updated: 26 Dec 2014

View Details
International WAGR Syndrome Association

Our mission is to promote international knowledge and awareness of WAGR syndrome and its complications and treatments, to stimulate research and to reach out to those affected by WAGR syndrome in an effort to improve their lives.

Last Updated: 12 Dec 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Wilms' tumor" for support, advocacy or research.

Trisomy 18 Foundation

The Trisomy 18 Foundation (T18F) is the leading national organization devoted exclusively to improving outcomes for Trisomy 18 families in the United States. Committed to the support of medical research in finding effective treatments and preventions for Trisomy 18. The T18F also educates patient families and physicians about prevention, diagnosis and the treatment of Trisomy 18. The T18F is an active advocate for the Trisomy 18 community, helping to raise awareness of this disease and the need for treatments. The T18F's website is the premier source for educating the public about Trisomy 18 and impacted families..

http://www.trisomy18.org

Last Updated: 26 Dec 2014

View Details
International WAGR Syndrome Association

Our mission is to promote international knowledge and awareness of WAGR syndrome and its complications and treatments, to stimulate research and to reach out to those affected by WAGR syndrome in an effort to improve their lives.

http://www.wagr.org

Last Updated: 12 Dec 2012

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Wilms' tumor" returned 256 free, full-text research articles on human participants. First 3 results:

Clinical factors in relapses of Wilms' tumor--results for the Polish Pediatric Solid Tumors Study Group.
 

Author(s): Ewa Niedzielska, Krzysztof Bronowicki, Wojciech Pietras, Krystyna Sawicz-Birkowska, Katarzyna Trybucka, Małgorzata Rąpała, Irena Karpińska-Derda, Andrzej Kurylak, Patrycja Marciniak-Stępak, Anna Panasiuk, Joanna Nurzyńska-Flak, Jarosław Peregud-Pogorzelski, Danuta Pietrys, Iwona Rurańska, Grażyna Sobol, Joanna Stefanowicz, Sabina Szymik-Kantorowicz, Małgorzata Zubowska, Jan Godziński

Journal: Adv Clin Exp Med. ;23(6):925-31.

 

The risk factors responsible for recurrences of Wilms' tumor (nephroblastoma) are still under discussion. The aim of the study was to analyze the relationship between relapses of Wilms' tumor and the patients' clinical history.

Last Updated: 27 Jan 2015

Go To URL
Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factors.
 

Author(s): Junjie Zhang, Fei Guo, Lei Wang, Wei Zhao, Da Zhang, Heying Yang, Jiekai Yu, Lili Niu, Fuquan Yang, Shu Zheng, Jiaxiang Wang

Journal:

 

Wilms' tumor is one of the most common malignant tumors observed in children, and its early diagnosis is important for late-stage treatment and prognosis. We previously screened and identified protein markers for Wilms' tumor; however, these markers lacked specificity, and some were ...

Last Updated: 16 Sep 2014

Go To URL
Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma.
 

Author(s): Valerie B Sampson, Justin M David, Isabel Puig, Pratima U Patil, Antonio García de Herreros, George V Thomas, Ayyappan K Rajasekaran

Journal:

 

The Wilms' tumor transcription factor (WT1) was originally classified as a tumor suppressor, but it is now known to also be associated with cancer progression and poor prognosis in several malignancies. WT1 plays an essential role in orchestrating a developmental process known as ...

Last Updated: 16 Jul 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Wilms' tumor" returned 15 free, full-text review articles on human participants. First 3 results:

Botryoid Wilms' tumor: a case report and review of the literature.
 

Author(s): Guofeng Xu, Jimeng Hu, Yeming Wu, Yongtao Xiao, Maosheng Xu

Journal:

 

Here, we report a new case of botryoid Wilms' tumor, a 4-year-old boy, who was referred to us with a chief complaint of dysuria and gross hematuria. The computed tomography and radical nephroureterectomy showed that a botryoid sarcoma-like appearance occupied the right renal pelvis ...

Last Updated: 23 May 2013

Go To URL
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.
 

Author(s): Ann Van Driessche, Zwi N Berneman, Viggo F I Van Tendeloo

Journal: Oncologist. 2012 ;17(2):250-9.

 

There is a growing body of evidence that Wilms' tumor protein 1 (WT1) is a promising tumor antigen for the development of a novel class of universal cancer vaccines. Recently, in a National Cancer Institute prioritization project, WT1 was ranked first in a list of 75 cancer antigens. ...

Last Updated: 27 Feb 2012

Go To URL
WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.
 

Author(s): Haruo Sugiyama

Journal: Jpn. J. Clin. Oncol.. 2010 May;40(5):377-87.

 

Wilms' tumor gene WT1 encodes a transcription factor and plays an important role in cell growth and differentiation. The WT1 gene is highly expressed in leukemia and various types of solid tumors, whereas WT1 is a tumor marker convenient for the detection of minimal residual disease ...

Last Updated: 4 May 2010

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Gene Expression Profiles to Categorize Wilms Tumors
 

Status: Recruiting

Condition Summary: Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Stage I Wilms Tumor; Stage II Wilms Tumor; Stage III Wilms Tumor; Stage IV Wilms Tumor; Stage V Wilms Tumor

 

Last Updated: 5 May 2015

Go to URL
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
 

Status: Recruiting

Condition Summary: Clear Cell Sarcoma of the Kidney; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Rhabdoid Tumor of the Kidney; Stage I Wilms Tumor; Stage II Wilms Tumor; Stage III Wilms Tumor; Stage IV Wilms Tumor; Stage V Wilms Tumor

 

Last Updated: 5 May 2015

Go to URL
Collaborative Wilms Tumour Africa Project
 

Status: Recruiting

Condition Summary: Wilms Tumour

 

Last Updated: 9 Dec 2014

Go to URL